Bidirectional regulation of mu-opioid and CB1-cannabinoid receptor in rats self-administering heroin or WIN 55,212-2

European Journal of Neuroscience

Volumn 25, Issue 7, 2007, Pages 2191-2200

  Fattore, Liana ^a,b   Viganò, Daniela ^c   Fadda, Paola ^b   Rubino, Tiziana ^c   Fratta, Walter ^a,b   Parolaro, Daniela ^c  

^a CNR   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

Addiction; Autoradiography; Binding; Reward; Self administration

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; DIAMORPHINE; MU OPIATE RECEPTOR;

AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN FUNCTION; BRAIN TISSUE; CAUDATE NUCLEUS; CONTROLLED STUDY; DRUG SELF ADMINISTRATION; HIPPOCAMPUS; HYPOTHALAMUS; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PUTAMEN; RAT; RECEPTOR BINDING; REWARD; VENTRAL TEGMENTUM;

ANALGESICS, OPIOID; ANIMALS; BENZOXAZINES; BRAIN; CANNABINOIDS; CYCLOHEXANOLS; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HEROIN; HUMANS; MALE; MORPHOLINES; NAPHTHALENES; RATS; RECEPTOR, CANNABINOID, CB1; RECEPTORS, OPIOID, MU; SELF ADMINISTRATION;

EID: 34147210041     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2007.05470.x     Document Type: Article

References (62)

1. Bernstein, M.A. & Welch, S.P. (1998) Mu-opioid receptor down-regulation and cAMP-dependent protein kinase phosphorylation in a mouse model of chronic morphine tolerance. Mol. Brain Res., 55, 237-242.
2. Brady, L.S., Herkenham, M., Long, J.B. & Rothman, R.B. (1989) Chronic morphine increases mu-opiate receptor binding in rat brain: a quantitative autoradiographic study. Brain Res., 477, 382-386.
3. Braida, D., Pozzi, M., Cavallini, R. & Sala, M. (2001a) Conditioned place preference induced by the cannabinoid agonist CP 55,940: interaction with the opioid system. Neuroscience, 104, 923-926.
4. Braida, D., Pozzi, M., Parolaro, D. & Sala, M. (2001b) Intracerebral self-administration of the cannabinoid receptor agonist CP 55,940 in the rat: interaction with the opioid system. Eur. J. Pharmacol., 413, 227-234.
5. Breivogel, C.S., Childers, S.R., Deadwyler, S.A., Hampson, R.E., Vogt, L.J. & Sim-Selley, L.J. (1999) Chronic delta9-tetrahydrocannabinol treatment produces a time-dependent loss of cannabinoid receptors and cannabinoid receptor-activated G proteins in rat brain. J. Neurochem., 73, 2447-2459.
6. Childers, S.R., Simantov, R. & Snyder, S.H. (1977) Enkephalin: radioimmunoassay and radioreceptor assay in morphine dependent rats. Eur. J. Pharmacol., 46, 289-293.
7. Corchero, J., Oliva, J.M., Garcia-Lecumberri, C., Martin, S., Ambrosio, E. & Manzanares, J. (2004) Repeated administration with Delta9- tetrahydrocannabinol regulates mu-opioid receptor density in the rat brain. J. Psychopharmacol., 18, 54-58.
8. Cordeaux, Y. & Hill, S.J. (2002) Mechanisms of cross-talk between G-protein-coupled receptors. Neurosignals, 11, 45-57.
9. Cossu, G., Ledent, C., Fattore, L., Imperato, A., Bohme, G.A., Parmentier, M. & Fratta, W. (2001) Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse. Behav. Brain Res., 118, 61-65.
10. Davis, M.E., Akera, T. & Brody, T.M. (1979) Reduction of opiate binding to brainstem slices associated with the development of tolerance to morphine in rats. J. Pharmacol. Exp. Ther., 211, 112-119.
11. De Vries, T.J., Homberg, J.R., Binnekade, R., Raaso, H. & Schoffelmeer, A.N. (2003) Cannabinoid modulation of the reinforcing and motivational properties of heroin and heroin-associated cues in rats. Psychopharmacology, 168, 164-169.
12. Deiana, S., Fattore, L., Spano, M.S., Cossu, G., Porcu, E., Fadda, P. & Fratta, W. (2006) Strain and schedule-dependent differences in the acquisition, maintenance and extinction of intravenous cannabinoid self-administration in rats. Neuropharmacology, November 10 [Epub ahead of print].
13. Ellgren, M., Spano, S.M. & Hurd, Y.L. (2006) Adolescent cannabis exposure alters opiate intake and opioid limbic neuronal populations in adult rats. Neuropsychopharmacology, July 5 [Epub ahead of print].
14. Fadda, P., Scherma, M., Spano, M.S., Salis, P., Melis, V., Fattore, L. & Fratta, W. (2006) Cannabinoid self-administration increases dopamine release in the nucleus accumbens. Neuroreport, 17, 1629-1632.
15. Fan, F., Tao, Q., Abood, M. & Martin, B.R. (1996) Cannabinoid receptor down-regulation without alteration of the inhibitory effect of CP 55,940 on adenylyl cyclase in the cerebellum of CP 55,940-tolerant mice. Brain Res., 706, 13-20.
16. Fattore, L., Cossu, G. & Fratta, W. (2002) Functional interaction between cannabinoids and opioids in animal models of drug addiction. Proceedings of the 'Frontiers in Addiction Research' NIDA Symposium Satellite at the SfN Meeting, 1-2 November 2002, Orlando (USA).
17. Fattore, L., Cossu, G., Martellotta, C.M. & Fratta, W. (2001) Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats. Psychopharmacology, 156, 410-416.
18. Fattore, L., Cossu, G., Spano, M.S., Deiana, S., Fadda, P., Scherma, M. & Fratta, W. (2004) Cannabinoids and reward: interactions with the opioid system. Crit. Rev. Neurobiol., 16, 147-158.
19. Fattore, L., Deiana, S., Spano, S.M., Cossu, G., Fadda, P., Scherma, M. & Fratta, W. (2005a) Endocannabinoid system and opioid addiction: behavioural aspects. Pharmacol. Biochem. Behav., 81, 343-359.
20. Fattore, L., Spano, M.S., Cossu, G., Deiana, S., Fadda, P. & Fratta, W. (2005b) Cannabinoid CB(1) antagonist SR 141716A attenuates reinstatement of heroin self-administration in heroin-abstinent rats. Neuropharmacology, 48, 1097-1104.
21. Fattore, L., Spano, M.S., Cossu, G., Deiana, S. & Fratta, W. (2003) Cannabinoid mechanism in reinstatement of heroin-seeking after a long period of abstinence in rats. Eur. J. Neurosci., 17, 1723-1726.
22. Fattore, L., Spano, S.M., Deiana, S., Melis, V., Cossu, G., Fadda, P. & Fratta, W. (2006) An endocannabinoid mechanism in relapse to drug seeking: a review of animal studies and clinical perspectives. Brain Res. Rev., July 11 [Epub ahead of print].
23. Henningfield, J.E., Cohen, C. & Heishman, S.J. (1991) Drug self-administration methods in abuse liability evaluation. Br. J. Addict., 86, 1571-1577.
24. Jacobs, E.H., Smit, A.B., de Vries, T.J. & Schoffelmeer, A.N. (2003) Neuroadaptive effects of active versus passive drug administration in addiction research. Trends Pharmacol. Sci., 24, 566-573.
25. Justinova, Z., Tanda, G., Munzar, P. & Goldberg, S.R. (2004) The opioid antagonist naltrexone reduces the reinforcing effects of Delta-9-tetrahydrocannabinol (THC) in squirrel monkeys. Psychopharmacology, 173, 186-194.
26. Kumar, A.M., Haney, M., Becker, T., Thompson, M.L., Kream, R.M. & Miczek, K. (1990) Effect of early exposure to delta-9-tetrahydrocannabinol on the levels of opioid peptides, gonadotropin-releasing hormone and substance P in the adult male rat brain. Brain Res., 525, 78-83.
27. Kumar, M.S., Patel, V. & Millard, W.J. (1984) Effect of chronic administration of delta 9-tetrahydrocannabinol on the endogenous opioid peptide and catecholamine levels in the diencephalon and plasma of the rat. Subst. Alcohol Actions Misuse, 5, 201-210.
28. Ledent, C., Valverde, O., Cossu, G., Petitet, F., Aubert, J.F., Beslot, F., Bohme, G.A., Imperato, A., Pedrazzini, T., Roques, B.P., Vassart, G., Fratta, W. & Parmentier, M. (1999) Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science, 283, 401-404.
29. Lupica, C.R., Riegel, A.C. & Hoffman, A.F. (2004) Marijuana and cannabinoid regulation of brain reward circuits. Br. J. Pharmacol., 143, 227-234.
30. Luttrell, L.M. & Lefkowitz, R.J. (2002) The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals. J. Cell. Sci., 115, 455-465.
31. Maher, C.E., Eisenach, J.C., Pan, H.L., Xiao, R. & Childers, S.R. (2001) Chronic intrathecal morphine administration produces homologous mu receptor/G-protein desensitization specifically in spinal cord. Brain Res., 895, 1-8.
32. Maher, C.E., Martin, T.J. & Childers, S.R. (2005) Mechanisms of mu-opioid receptor/G-protein desensitization in brain by chronic heroin administration. Life Sci., 77, 1140-1154.
33. Manzanares, J., Corchero, J., Romero, J., Fernandez-Ruiz, J.J., Ramos, J.A. & Fuentes, J.A. (1998) Chronic administration of cannabinoids regulates proenkephalin mRNA levels in selected regions of the rat brain. Mol. Brain. Res., 55, 126-132.
34. Manzanares, J., Corchero, J., Romero, J., Fernandez-Ruiz, J.J., Ramos, J.A. & Fuentes, J.A. (1999) Pharmacological and biochemical interactions between opioids and cannabinoids. Trends Pharmacol. Sci., 20, 287-294.
35. Manzanedo, C., Aguilar, M.A., Rodriguez-Arias, M., Navarro, M. & Minarro, J. (2004) Cannabinoid agonist-induced sensitisation to morphine place preference in mice. Neuroreport, 15, 1373-1377.
36. Navarro, M., Carrera, M.R., Fratta, W., Valverde, O., Cossu, G., Fattore, L., Chowen, J.A., Gomez, R., del Arco, I., Villanua, M.A., Maldonado, R., Koob, G.F. & Rodriguez de Fonseca, F. (2001) Functional interaction between opioid and cannabinoid receptors in drug self-administration. J. Neurosci., 21, 5344-5350.
37. Nestler, E.J. (1992) Molecular mechanisms of drug addiction. J. Neurosci., 12, 2439-2450.
38. Noble, F. & Cox, B.M. (1996) Differential desensitization of mu- and delta-opioid receptors in selected neural pathways following chronic morphine treatment. Br. J. Pharmacol., 117, 161-169.
39. O'Brien, C.P. & Gardner, E.L. (2005) Critical assessment of how to study addiction and its treatment: human and non-human animal models. Pharmacol. Ther., 108, 18-58.
40. Parolaro, D., Viganò, D. & Rubino, T. (2005) Endocannabinoids and drug dependence. Curr. Drug Targ., 4, 643-655.
41. Paxinos, G. & Watson, C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, London.
42. Pickel, V.M., Chan, J., Kash, T.L., Rodriguez, J.J. & MacKie, K. (2004) Compartment-specific localization of cannabinoid 1 (CB1) and mu-opioid receptors in rat nucleus accumbens. Neuroscience, 127, 101-112.
43. Rodrìguez, J.J., Mackie, K. & Pickel, V.M. (2001) Ultrastructural localization of the CB1 cannabinoid receptor in mu-opioid receptor patches of the rat caudate putamen nucleus. J. Neurosci., 21, 823-833.
44. Romero, J., Berrendero, F., Garcia-Gil, L., Ramos, J.A. & Fernandez-Ruiz, J.J. (1998) Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTP gamma S binding and cannabinoid receptor mRNA levels in the basal ganglia and the cerebellum of adult male rats chronically exposed to delta 9-tetrahydrocannabinol. J. Mol. Neurosci., 11, 109-119.
45. Romero, J., Garcia-Palomero, E., Castro, J.G., Garcia-Gil, L., Ramos, J.A. & Fernandez-Ruiz, J.J. (1997) Effects of chronic exposure to delta9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions. Mol. Brain Res., 46, 100-108.
46. Rubino, T., Tizzoni, L., Viganò, D., Massi, P. & Parolaro, D. (1997) Modulation of rat brain cannabinoid receptors after chronic morphine treatment. Neuroreport, 8, 3219-3223.
47. Rubino, T., Viganò, D., Costa, B., Colleoni, M. & Parolaro, D. (2000c) Loss of cannabinoid-stimulated guanosine 5′-O-(3-[(35) S]thiotriphosphate) binding without receptor down-regulation in brain regions of anandamide-tolerant rats. J. Neurochem., 75, 2478-2484.
48. Rubino, T., Viganò, D., Massi, P. & Parolaro, D. (2000b) Changes in the cannabinoid receptor binding, G protein coupling, and cyclic AMP cascade in the CNS of rats tolerant to and dependent on the synthetic cannabinoid compound CP55,940. J. Neurochem., 75, 2080-2086.
49. Rubino, T., Viganò, D., Massi, P., Spinello, M., Zagato, E., Giagnoni, G. & Parolaro, D. (2000a) Chronic delta-9-tetrahydrocannabinol treatment increases cAMP levels and cAMP-dependent protein kinase activity in some rat brain regions. Neuropharmacology, 39, 1331-1336.
50. Selley, D.E., Nestler, E.J., Breivogel, C.S. & Childers, S.R. (1997a) Opioid receptor-coupled G-proteins in rat locus coeruleus membranes: decrease in activity after chronic morphine treatment. Brain Res., 746, 10-18.
51. Selley, D.E., Sim, L.J., Xiao, R., Liu, Q. & Childers, S.R. (1997b) Mu-Opioid receptor-stimulated guanosine-5′-O-(gamma-thio)-triphosphate binding in rat thalamus and cultured cell lines: signal transduction mechanisms underlying agonist efficacy. Mol. Pharmacol., 51, 87-96.
52. Sim, L.J., Hampson, R.E., Deadwyler, S.A. & Childers, S.R. (1996b) Effects of chronic treatment with delta9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPgammaS autoradiography in rat brain. J. Neurosci., 16, 8057-8066.
53. Sim, L.J., Selley, D.E., Dworkin, S.I. & Childers, S.R. (1996a) Effects of chronic morphine administration on mu opioid receptor-stimulated [35S]GTPgammaS autoradiography in rat brain. J. Neurosci., 16, 2684-2692.
54. Sim-Selley, L.J., Selley, D.E., Vogt, L.J., Childers, S.R. & Martin, T.J. (2000) Chronic heroin self-administration desensitizes mu opioid receptor-activated G-proteins in specific regions of rat brain. J. Neurosci., 20, 4555-4562.
55. Singh, M.E., Verty, A.N., McGregor, I.S. & Mallet, P.E. (2004) A cannabinoid receptor antagonist attenuates conditioned place preference but not behavioural sensitization to morphine. Brain Res., 1026, 244-253.
56. Solinas, M., Panlilio, L.V., Antoniou, K., Pappas, L.A. & Goldberg, S.R. (2003) The cannabinoid CB1 antagonist N-piperidinyl-5-(4-chlorophenyl)-1- (2,4-dichlorophenyl)-4-methylpyrazole-3-carboxamide (SR-141716A) differentially alters the reinforcing effects of heroin under continuous reinforcement, fixed ratio, and progressive ratio schedules of drug self-administration in rats. J. Pharmacol. Exp. Ther., 306, 93-102.
57. Spano, M.S., Ellgren, M., Wang, X. & Hurd, Y.L. (2006) Prenatal cannabis exposure increases heroin seeking in adults with allostatic changes in limbic enkephalin systems. Biol. Psych., July 27 [Epub ahead of print].
58. Spano, M.S., Fattore, L., Cossu, G., Deiana, S., Fadda, P. & Fratta, W. (2004) CB1 receptor agonist and heroin, but not cocaine, reinstate cannabinoid-seeking behaviour in the rat. Br. J. Pharmacol., 143, 343-350.
59. Viganò, D., Cascio, M.G., Rubino, T., Fezza, F., Vaccani, A., Di Marzo, V. & Parolaro, D. (2003a) Chronic morphine modulates the contents of the endocannabinoid, 2-arachidonoyl glycerol, in rat brain. Neuropsychopharmacology, 28, 1160-1167.
60. Viganò, D., Rubino, T., Di Chiara, G., Ascari, I., Massi, P. & Parolaro, D. (2003b) Mu opioid receptor signaling in morphine sensitization. Neuroscience, 117, 921-929.
61. Viganò, D., Rubino, T., Vaccani, A., Bianchessi, S., Marmorato, P., Castiglioni, C. & Parolaro, D. (2005) Molecular mechanisms involved in the asymmetric interaction between cannabinoid and opioid systems. Psychopharmacology, 182, 527-536.
62. Vigano, D., Valenti, M., Cascio, M.G., Di Marzo, V., Parolaro, D. & Rubino, T. (2004) Changes in endocannabinoid levels in a rat model of behavioural sensitization to morphine. Eur. J. Neurosci., 20, 1849-1857.